Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

Hamill, Victoria; Wong, Stanley; Benselin, Jennifer; Krajden, Mel; Hayes, Peter C; Mutimer, David; Yu, Amanda; Dillon, John F; Gelson, William; Velásquez García, Hector A; Yeung, Alan; Johnson, Philip; Barclay, Stephen T; Alvarez, Maria; Toyoda, Hidenori; Agarwal, Kosh; Fraser, Andrew; Bartlett, Sofia; Aldersley, Mark; Bathgate, Andy; Binka, Mawuena; Richardson, Paul; Morling, Joanne R; Ryder, Stephen D; MacDonald, Douglas; Hutchinson, Sharon; Barnes, Eleanor; Guha, Indra Neil; Irving, William L; Janjua, Naveed Z; Innes, Hamish

doi:10.1136/bmj-2022-074001

All Outputs (2)

Using a machine learning model to risk stratify for the presence of significant liver disease in a primary care population (2023)
Journal Article

Background: Current strategies for detecting significant chronic liver disease (CLD) in the community are based on the extrapolation of diagnostic tests used in secondary care settings. Whilst this approach provides clinical utility, it has limitatio... Read More about Using a machine learning model to risk stratify for the presence of significant liver disease in a primary care population.

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (2023)
Journal Article

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design Population based cohort study.... Read More about Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.